IP Library Granted Patent US 12,440,671
Granted Patent B2
US 12,440,671 · App. 18/511,562 · Granted Oct 14, 2025

Conductive pad with improved air flow and methods of production and use thereof

Inventor: Richard Deslauriers (Woodbury, CT)
Assignee: Novocure GmbH
A61N1/36002A61N1/0492A61N1/36034A61N1/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,440,671
App. No.
18/511,562
Granted
Oct 14, 2025
Kind
B2
Abstract

A system for generating a TTField is herein described. The system comprises a generator configured to generate an electrical signal; a first lead coupled to the generator and a first conductive pad and configured to carry the electrical signal; the first conductive pad having a first electrode element electrically coupled to a first conductive gel element to supply electrical current to the first conductive gel element; a second lead coupled to the generator and a second conductive pad and configured to carry the electrical signal; and the second conductive pad having the second electrode element electrically coupled to a second conductive gel element to supply electrical current to the second conductive gel element, wherein the first conductive gel element and the second conductive gel element are each configured to be in contact with a patient's skin and each supporting a shaping member adjacent to one or more air channel.

Claims (36)

1. A system, comprising:

a generator configured to generate an electrical signal having an alternating current waveform at a frequency in a range from 50 kHz to 500 kHz as a TTField;

a first conductive lead electrically coupled to the generator, the first conductive lead configured to carry the electrical signal;

a first conductive pad comprising:

a topcoat layer;

a first electrode element connected to the topcoat layer and electrically coupled to the first conductive lead, and configured to receive the electrical signal from the generator via the first conductive lead;

a first conductive gel element electrically coupled to the first electrode element so as to receive an electrical current from the first electrode element, the first conductive gel element configured to be in contact with a patient's skin, the first conductive gel element including a first conductive gel layer and a first shaping member, the first shaping member positioned within the first conductive gel layer and having a first side and a second side, wherein the first conductive gel layer includes a plurality of protrusions and one or more first air channel on the second side of the first shaping member;

a second conductive lead electrically coupled to the generator, the second conductive lead configured to carry the electrical signal; and

a second conductive pad having a second electrode element electrically coupled to a second conductive gel element to supply electrical current to the second conductive gel element, wherein the second electrode element is electrically coupled to the second conductive lead, and the second conductive gel element is configured to be in contact with a patient's skin, the second conductive gel element having one or more second air channel.

2. The system of claim 1 , wherein at least one protrusion of the plurality of protrusions of the first conductive gel layer is configured to enable electrical conductivity.

3. The system of claim 2 , wherein the first shaping member is a mold having a plurality of apertures formed in the mold.

4. The system of claim 3 , wherein the apertures are positioned in the mold in a lattice pattern.

5. The system of claim 3 , wherein the plurality of apertures in the mold of the first shaping member are configured to form the plurality of protrusions and the one or more first air channel in the first conductive gel layer.

6. The system of claim 1 , wherein the first shaping member is integral with the first conductive gel element.

7. A conductive pad, comprising:

a topcoat layer;

an electrode element connected to the topcoat layer, and configured to receive an electrical signal from a generator producing the electrical signal as a TTField; and

a conductive gel element electrically coupled to the electrode element so as to receive an electrical current from the electrode element, the conductive gel element configured to be in contact with a patient's skin, the conductive gel element including a conductive gel layer and a shaping member, the shaping member positioned within the conductive gel layer and having a first side and a second side, wherein the conductive gel layer includes a plurality of protrusions and one or more air channel on the second side of the shaping member.

8. The conductive pad of claim 7 , wherein the shaping member includes a mold having a plurality of apertures.

9. The conductive pad of claim 7 , wherein the shaping member is formed of a non-conductive material.

10. The conductive pad of claim 7 , wherein the shaping member is formed of a mesh.

11. The conductive pad of claim 10 , wherein the mesh is a polymeric material mesh.

12. The conductive pad of claim 11 , wherein the polymeric material mesh is nylon mesh.

13. The conductive pad of claim 7 , wherein the second side of the shaping member is open to the one or more air channel.

14. The conductive pad of claim 7 , wherein the second side of the shaping member is exposed to the one or more air channel.

15. The conductive pad of claim 14 , wherein the second side of the shaping member is exposed to the one or more air channel without any intervening structure between the second side of the shaping member and the one or more air channel.

16. The conductive pad of claim 14 , wherein the second side of the shaping member defines a boundary of the one or more air channel without any intervening structure between the second side of the shaping member and the one or more air channel.

17. A method, comprising:

applying at least two conductive pads to a patient, the conductive pads being coupled to a generator, the generator configured to generate an electrical signal having an alternating current waveform at frequencies in a range from 50 kHz to 500 kHz as a TTField, each of the conductive pads comprising:

a topcoat layer;

an electrode element connected to the topcoat layer and configured to receive the electrical signal from the generator; and

a conductive gel element electrically coupled to the electrode element so as to receive an electrical current from the electrode element, the conductive gel element in contact with a patient's skin, the conductive gel element including a conductive gel layer and a shaping member, the shaping member positioned within the conductive gel layer and having a first side and a second side, wherein the conductive gel layer includes a plurality of protrusions and one or more air channel on the second side of the shaping member; and

activating the generator to supply the electrical signal to the electrode elements, thereby supplying electrical current to the patient through the conductive gel element.

18. The method of claim 17 , wherein the shaping member includes a mold having a plurality of apertures.

19. The method of claim 17 , wherein the second side of the shaping member is open to the one or more air channel.

20. The method of claim 17 , wherein the second side of the shaping member is exposed to the one or more air channel.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2023
From: DESLAURIERS, RICHARD
To: NOVOCURE GMBH
Reel/Frame 065604/0082 →
Continuity (11)
Continuation 17313114 · May 6, 2021
Provisional Application 63141315 · Jan 25, 2021
Provisional Application 63128276 · Dec 21, 2020
Provisional Application 63085476 · Sep 30, 2020
Provisional Application 63068213 · Aug 20, 2020
Provisional Application 63061316 · Aug 5, 2020
Provisional Application 63061419 · Aug 5, 2020
Provisional Application 63046364 · Jun 30, 2020
Provisional Application 63030138 · May 26, 2020
Provisional Application 63020636 · May 6, 2020
Related Publication 20240165406A1 · May 23, 2024
References Cited (66)
US 5285415A · Buckley et al. · 1994 [cited by applicant]
US 5974344A · Shoemaker, II · 1999 [cited by examiner]
US 6038464A · Axelgaard et al. · 2000 [cited by applicant]
US 6263226B1 · Axelgarrd et al. · 2001 [cited by applicant]
US 6317629B1 · Haak et al. · 2001 [cited by applicant]
US 6347246B1 · Perrault et al. · 2002 [cited by applicant]
US 7016725B2 · Palti · 2006 [cited by applicant]
US 7089054B2 · Palti · 2006 [cited by applicant]
US 7146210B2 · Palti · 2006 [cited by applicant]
US 7333852B2 · Palti · 2008 [cited by applicant]
US 7565205B2 · Palti · 2009 [cited by applicant]
US 8244345B2 · Palti · 2012 [cited by applicant]
US 8715203B2 · Palti · 2014 [cited by applicant]
US 8764675B2 · Palti · 2014 [cited by applicant]
US 9731108B2 · Mathew et al. · 2017 [cited by applicant]
US 10188851B2 · Wenger et al. · 2019 [cited by applicant]
US 10441776B2 · Kirson et al. · 2019 [cited by applicant]
US 11058886B1 · Matloubian et al. · 2021 [cited by applicant]
US 20020183804A1 · Malaney et al. · 2002 [cited by applicant]
US 20030069627A1 · Guintoli et al. · 2003 [cited by applicant]
US 20030134545A1 · McAdams et al. · 2003 [cited by applicant]
US 20030153964A1 · Al-Lamee et al. · 2003 [cited by applicant]
US 20060276858A1 · Palti · 2006 [cited by applicant]
US 20090002067A1 · Kronberg · 2009 [cited by applicant]
US 20090043346A1 · Palti et al. · 2009 [cited by applicant]
US 20100191316A1 · Buhlmann et al. · 2010 [cited by applicant]
US 20100204560A1 · Salahieh · 2010 [cited by applicant]
US 20120149968A1 · Brighton · 2012 [cited by applicant]
US 20140073896A1 · Hyatt et al. · 2014 [cited by applicant]
US 20150321000A1 · Rosenbluth et al. · 2015 [cited by applicant]
US 20170157398A1 · Wong et al. · 2017 [cited by applicant]
US 20170165470A1 · Jeffery · 2017 [cited by applicant]
US 20180117302A1 · Clegg · 2018 [cited by applicant]
US 20180160933A1 · Urman et al. · 2018 [cited by applicant]
US 20190048193A1 · Naier et al. · 2019 [cited by applicant]
US 20190117956A1 · Wenger et al. · 2019 [cited by applicant]
US 20190217078A1 · Yang et al. · 2019 [cited by applicant]
US 20190217079A1 · Kato et al. · 2019 [cited by applicant]
US 20190307781A1 · Krex et al. · 2019 [cited by applicant]
US 20190308016A1 · Wenger et al. · 2019 [cited by applicant]
US 20190314638A1 · Kreindel · 2019 [cited by applicant]
US 20190321636A1 · Law et al. · 2019 [cited by applicant]
US 20200101278A1 · Freeman · 2020 [cited by examiner]
US 20200324107A1 · Nishizawa · 2020 [cited by applicant]
US 20210213280A1 · Kuwahata · 2021 [cited by applicant]
US 20210290944A1 · Hong et al. · 2021 [cited by applicant]
US 20220218983A1 · Brooks et al. · 2022 [cited by applicant]
CN 103585715A · 2014 [cited by applicant]
CN 110180082A · 2019 [cited by applicant]
EP 3067073A1 · 2016 [cited by applicant]
JP 2002501804A · 2002 [cited by applicant]
JP 2004510481A · 2004 [cited by applicant]
JP 2006513739A · 2006 [cited by applicant]
JP 2010532644A · 2010 [cited by applicant]
JP 2019524206A · 2019 [cited by applicant]
JP 2022567156A · 2023 [cited by applicant]
KR 1020100028761 · 2010 [cited by applicant]
WO WO9939635 · 1999 [cited by applicant]
WO WO0228279A1 · 2002 [cited by applicant]
WO WO2004030760A3 · 2004 [cited by applicant]
WO WO2009003123A1 · 2008 [cited by applicant]
WO WO2018002879A1 · 2018 [cited by applicant]
WO WO2018081423A1 · 2018 [cited by applicant]
WO WO2020070914A1 · 2020 [cited by applicant]
International Search Report and Written Opinion (PCT/US2021/031119); Aug. 25, 2021; 12 pgs. [cited by applicant]
Japanese Patent Office, Notification of Reasons for Refusal regarding Japanese Patent Application No. 2022-567156 (English machine translation from JPO J-PlatPat); Feb. 18, 2025; 16 pgs. [cited by applicant]